Free Trial

B. Riley Analysts Lift Earnings Estimates for UAMY

United States Antimony logo with Basic Materials background

United States Antimony Co. (NYSE:UAMY - Free Report) - Equities researchers at B. Riley boosted their Q2 2025 earnings per share estimates for United States Antimony in a research report issued on Tuesday, April 15th. B. Riley analyst N. Giles now forecasts that the company will earn $0.04 per share for the quarter, up from their prior estimate of $0.01. B. Riley has a "Buy" rating on the stock. The consensus estimate for United States Antimony's current full-year earnings is ($0.01) per share. B. Riley also issued estimates for United States Antimony's Q3 2025 earnings at $0.07 EPS and FY2025 earnings at $0.18 EPS.

Separately, HC Wainwright increased their target price on United States Antimony from $2.50 to $2.60 and gave the company a "buy" rating in a research report on Friday, March 21st.

View Our Latest Stock Analysis on United States Antimony

United States Antimony Price Performance

NYSE UAMY traded down $0.29 during trading hours on Friday, reaching $3.20. The company's stock had a trading volume of 5,664,152 shares, compared to its average volume of 1,915,118. The company has a quick ratio of 5.84, a current ratio of 6.24 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $366.82 million, a price-to-earnings ratio of -80.00 and a beta of 0.21. The firm's 50-day moving average price is $1.99 and its 200-day moving average price is $1.51. United States Antimony has a 1 year low of $0.21 and a 1 year high of $3.60.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Jefferies Financial Group Inc. acquired a new stake in shares of United States Antimony in the fourth quarter worth approximately $52,000. Squarepoint Ops LLC purchased a new stake in United States Antimony during the 4th quarter valued at about $209,000. Two Sigma Advisers LP acquired a new stake in United States Antimony in the 4th quarter valued at about $407,000. Two Sigma Investments LP acquired a new position in shares of United States Antimony during the 4th quarter worth approximately $565,000. Finally, Millennium Management LLC grew its position in shares of United States Antimony by 228.4% in the fourth quarter. Millennium Management LLC now owns 100,793 shares of the company's stock valued at $178,000 after purchasing an additional 70,105 shares in the last quarter. 9.49% of the stock is owned by institutional investors and hedge funds.

United States Antimony Company Profile

(Get Free Report)

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.

Further Reading

Should You Invest $1,000 in United States Antimony Right Now?

Before you consider United States Antimony, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and United States Antimony wasn't on the list.

While United States Antimony currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines